SHOUCHENG is accelerating its transformation from a pure investor to a comprehensive full-chain service provider.
SHOUCHENG Holdings Limited (0697.HK) released its interim results for 2025 on August 31st. The financial report shows that in the first half of this year, SHOUCHENG achieved operating revenue of HK$731 million, up 36% year-on-year; net profit attributable to shareholders reached HK$339 million, up 30% year-on-year; and gross profit totaled HK$295 million, up 26% year-on-year.
In the asset financing business segment, SHOUCHENG recorded revenue of HK$220 million in the first half, up 69% year-on-year, becoming a key driver of overall performance growth. Through a multi-billion infrastructure real estate equity investment stabilization fund jointly established with China Life, SHOUCHENG continues to deepen its presence in the REITs market and has grown to become one of the largest industrial investors in China.
SHOUCHENG has successively completed strategic allocation investments in South Runze/GDS Data Center REIT, Shounong Industrial Park REIT, and Huadian Clean Energy REIT, covering key sectors including data centers and clean energy. This has enabled systematic deployment across all infrastructure asset categories, further building complete closed-loop capabilities from fund investment to asset exit.
Meanwhile, SHOUCHENG has achieved significant results in equity investment. Through its various industrial funds, SHOUCHENG has invested in and deployed leading robotics companies including Unitree Robotics, Galaxy General, Starmap, CloudMinds, Songyan Power, Evolution Accelerated, and Narwal, among others.
Previously, SHOUCHENG achieved excellent results in projects including Li Auto, Horizon Robotics, Zhaogang.com, Piesat Information Technology, and Silan Microelectronics. Its equity investment funds achieved over threefold book returns as of early this year, generating impressive exit gains.
As one of the earliest listed companies in China to systematically deploy in the robotics industry, SHOUCHENG is accelerating its transformation from pure investor to full-chain service provider. Through the multi-billion Beijing Robotics Industry Development Investment Fund and related industrial funds, SHOUCHENG has invested in dozens of leading companies covering humanoid robots, core components, and other key areas. This investment matrix has established SHOUCHENG's leading position in the embodied intelligence industry.
Notably, SHOUCHENG is further strengthening and supplementing the robotics industry chain upstream. Recently, SHOUCHENG announced the establishment of a "Robotics Advanced Materials Industry Company" through its wholly-owned subsidiary Shouwo Investment, focusing on electronic skin, tendons, lightweight PEEK materials, and other core advanced materials. This initiative not only fills gaps in key industrial chain segments but also helps improve the technical performance of portfolio companies in tactile perception, flexible control, and lightweight applications, further perfecting the complete industrial chain ecosystem represented by humanoid robots.
At the application implementation level, SHOUCHENG is promoting the real entry of robots into production and daily life scenarios. Beijing SHOUCHENG Robotics Technology Industry Co., Ltd., a wholly-owned subsidiary of SHOUCHENG, is deploying comprehensive applications across multiple dimensions of the robotics industry.
SHOUCHENG has created a "Didi-style" supply-demand matching platform in the robotics field through sales agency, financing leases, and secondary development, promoting efficient collaboration throughout the industrial chain. Currently, SHOUCHENG's robotics industrialization deployment is beginning to take shape.
The strategic cooperation with IAT Automobile means robots will deeply participate in automotive industry chain assembly, intelligent detection, and electrification production, promoting cross-border integration of "robots + automotive."
In smart transportation, the Chengdu Huanmao ICD automatic charging experience station jointly created by SHOUCHENG and Wanxun Technology has been put into operation, achieving large-scale application of robots in new energy vehicle owner services.
In healthcare, Beijing University Shougang Hospital has introduced surgical robots developed by contracted companies in SHOUCHENG's robotics ecosystem for clinical surgery and training education, marking the acceleration of domestic surgical robots toward commercial application and breakthroughs in high-end medical equipment.
Additionally, SHOUCHENG is exploring a "Robot 4S Store" model, planning to create an integrated retail service system combining display, sales, maintenance, and experience. This model aims to bridge the "last mile" of the robotics industry and promote genuine integration of robots into daily life.
According to public roadshow information from August 31st, SHOUCHENG will distribute a total of HK$1.159 billion in dividends for the full year 2025 and repurchase over 40 million shares, with a dividend yield of nearly 8%, ranking among the top in the Hong Kong stock market.
Kang Yu, General Manager of SHOUCHENG's Board Office, stated: "We need to create long-term growth potential for shareholders - SHOUCHENG's various businesses are in their best development period in history, and we are just setting sail; at the same time, we must ensure certainty of shareholder returns - dividends alone approach HK$1.2 billion this year, and continuous share buybacks demonstrate management's firm confidence in the company's long-term development."
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.